Arkadios Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Arkadios Wealth Advisors's BMY Position: Q2 2026 in Review
Arkadios Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 7.3% in Q2 2026, buying an estimated $1.25M and bringing the position to 320,925 shares worth $18.5M. The position accounts for 0.28% of the portfolio, ranked #75.
Arkadios Wealth Advisors first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Arkadios Wealth Advisors held 320,925 shares of Bristol-Myers Squibb worth $18.5M as of Q2 2026.
- Arkadios Wealth Advisors bought 21,701 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.25M.
- Bristol-Myers Squibb made up 0.28% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #75 holding.
- Arkadios Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.